Palvella Therapeutics Inc (PVLA) Options

I now wish I had bought more UVIX yesterday.

I too will now watch for an entry into SVIX. GLTY

Doc, I replied at length to you but the post never materialized.  This new app blows.  

Careful, a pumper/promoter here might read that post you made and say "look! shorty wants your shares before the big squeeze"!

You might be right. I’m a bit bearish outside of ELTP.

is this the only bird flu stock running, watching other's out there no traction on them yet

Al my will power to not enter a NUKK short

GTCH mm's playing games or news on the way ,,, there was zip volume till the other day now renewed intrest ? coincidential ? to many questions as always.....................................

https://www.google.com/maps/place/Universal+Plant+Services/ @GGraessle.1301381,16.5z/data=!4m6!3m5!1s0x8640a1ef1508faaf:0x8234d789a403e8da!8m2!3d29.7036551!4d-95.1284956!16s%2Fg%2F12632mmbd?hl=en-US&entry=ttu&g_ep=EgoyMDI0MTIxMS4wIKXMDSoASAFQAw%3D%3D

***** NO SIR !!! 🚽UBQU🚽 Does not have 5 million in revenues , point in fact financials are not very good and can be found here

https://www.otcmarkets.com/stock/UBQU/disclosure

ENOUGH SAID 🤪 !!!

LOL 😄

got stopped out 5.17
needs to gain traction another day

Lmao perhaps the person saw last december new years letter and decided wtf lol

Yep and I appreciate your LITM call, meant  to tell you , I clipped a couple goodies today !!! on that one, appreciate you my man!!!

Rarely give out my win %, but today +31.4% at moment and craziest part on a HUGE monster red day on market...KRE IBIT puts, AEMD pop, LITM super nova boom monster and many others...stick around we may get more ;)

The below is so TRUE in regards to QSEP

A stock basher is someone who manipulates the market to cause a drop in asset prices.

Stock bashers disseminate misinformation in the hopes that investors will believe the false claims and sell their stock before the price drops.

Competition is high among API manufacturers in the US. Costs are also high for the APIs they produce.

Johnson Matthey was an example of an API manufacturer that couldn't make it in the US.

Very few if any cancer trials also have a decade long Specials program to observe.  LP, CDF, MHRA, NICE have wasted an incredible amount of time, assuming L shows actual efficacy.  That's why I think there really is no actual efffacy.  Makes no sense otherwise.   

Ok, but I sure didn't see you posting about underperforming the market when it was down 15-20% and the markets were green or just slightly in the red. Those are the facts too.

jmho

Probably X or Walter 🤣

You're exactly correct, increased revenues speaks volumes on what management has accomplished. $IQST

This could get pretty wild after hours if they let it run

Some one please check me on this.

TMaga I hope you read the whole report.
Besides his Class B preferred, Remo was paid 100,000 Class C preferred shares (restricted) as payment of $2.6 million debt. (Aug 2024 spreadsheet page 5).
Go back to page 4 (for Class C) and if I r

we'll see